Athira Pharma Inc (ATHA)

Mar 26, 2026

LeonaBio Updates Investors on 2025 Results and Strategy - TipRanks

Mar 26, 2026

Mar 26, 2026

LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update - Bitget

Mar 26, 2026

Mar 26, 2026

LeonaBio (NASDAQ: LONA) boosts cash to fund Phase 3 breast cancer drug - Stock Titan

Mar 26, 2026

Mar 25, 2026

Momentum Shift: Can Athira Pharma Inc be recession proof2026 Pullback Review & Low Risk High Win Rate Picks - baoquankhu1.vn

Mar 25, 2026

Mar 25, 2026

Contrasting Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME) - Defense World

Mar 25, 2026

Mar 20, 2026

What dividend growth rate does Athira Pharma Inc offer2026 Short Interest & Accurate Intraday Trading Signals - baoquankhu1.vn

Mar 20, 2026

Mar 19, 2026

LeonaBio shareholders approve equity plan and increase in authorized shares - Investing.com India

Mar 19, 2026

Mar 19, 2026

LeonaBio (ATHA) wins approval for 2026 equity plan and major share increase - Stock Titan

Mar 19, 2026

Mar 19, 2026

Published on: 2026-03-20 02:58:44 - baoquankhu1.vn

Mar 19, 2026

Mar 17, 2026

Risk Report: Can Athira Pharma Inc ride the EV wave2026 Macro Impact & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Mar 17, 2026

Mar 17, 2026

Earnings Miss: Is Athira Pharma Inc subject to activist investor interest2026 Trading Volume Trends & Trade Opportunity Analysis Reports - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Athira Pharma shares surge after securing rights to phase 3 breast cancer therapy - MSN

Mar 16, 2026

Mar 12, 2026

Shorts Report: Can Athira Pharma Inc be recession proofEarnings Risk Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn

Mar 12, 2026

Mar 11, 2026

Top Athira Pharma (LONA) Competitors 2026 - MarketBeat

Mar 11, 2026

Mar 11, 2026

[DEFR14A] LeonaBio, Inc. Revised Proxy Statement - Stock Titan

Mar 11, 2026

Mar 11, 2026

Reviewing Athira Pharma (NASDAQ:LONA) and Inhibikase Therapeutics (NASDAQ:IKT) - Defense World

Mar 11, 2026

Mar 10, 2026

Reviewing Athira Pharma (NASDAQ:LONA) and Liminatus Pharma (NASDAQ:LIMN) - Defense World

Mar 10, 2026

Mar 07, 2026

Sentiment Review: Is Athira Pharma Inc subject to activist investor interest2025 Earnings Surprises & Low Risk Entry Point Tips - baoquankhu1.vn

Mar 07, 2026

Mar 07, 2026

Should I invest in Athira Pharma Inc before earningsPortfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026

LeonaBio CEO Litton sells $27,687 in shares By Investing.com - Investing.com India

Mar 06, 2026

Mar 05, 2026

LeonaBio CEO Litton sells $27,687 in shares - Investing.com South Africa

Mar 05, 2026

Mar 05, 2026

Renninger, LeonaBio CFO, sells $4.9k in LONA stock - Investing.com Australia

Mar 05, 2026

Mar 05, 2026

LeonaBio (ATHA) CEO converts 22,254 RSUs and sells shares for taxes - Stock Titan

Mar 05, 2026

Mar 05, 2026

LeonaBio (LONA) CMO covers RSU tax bill with share sale - Stock Titan

Mar 05, 2026

Mar 04, 2026

LeonaBio (NASDAQ: ATHA) files to sell 22,254 shares after RSU lapse - Stock Titan

Mar 04, 2026

Mar 04, 2026

Athira Pharma (LONA) Stock Forecast and Price Target 2026 $LONA - MarketBeat

Mar 04, 2026

Mar 04, 2026

Comparing Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME) - Defense World

Mar 04, 2026

Mar 03, 2026

Breakout Watch: Whats the beta of Athira Pharma Inc stockSwing Trade & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Mar 03, 2026

Mar 03, 2026

Financial Contrast: Athira Pharma (NASDAQ:LONA) vs. Prime Medicine (NASDAQ:PRME) - Defense World

Mar 03, 2026

Mar 02, 2026

Athira Pharma (LONA) 10K Form and SEC Filings 2026 $LONA - MarketBeat

Mar 02, 2026

Mar 02, 2026

Athira Pharma (NASDAQ:LONA) versus Inhibikase Therapeutics (NASDAQ:IKT) Head-To-Head Analysis - Defense World

Mar 02, 2026

Feb 27, 2026

Athira Pharma (NASDAQ:LONA) Now Covered by Analysts at Cantor Fitzgerald - Defense World

Feb 27, 2026

Feb 26, 2026

Cantor Fitzgerald initiates Leona Bio stock with overweight rating By Investing.com - Investing.com Australia

Feb 26, 2026

Feb 26, 2026

Cantor Fitzgerald initiates Leona Bio stock with overweight rating - Investing.com UK

Feb 26, 2026

Feb 26, 2026

Reviewing Prime Medicine (NASDAQ:PRME) and Athira Pharma (NASDAQ:LONA) - Defense World

Feb 26, 2026

Feb 25, 2026

Analyzing Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME) - Defense World

Feb 25, 2026

Feb 25, 2026

Critical Analysis: Liminatus Pharma (NASDAQ:LIMN) and Athira Pharma (NASDAQ:LONA) - Defense World

Feb 25, 2026

Feb 25, 2026

Analyzing Athira Pharma (NASDAQ:LONA) and Inhibikase Therapeutics (NASDAQ:IKT) - Defense World

Feb 25, 2026

Feb 24, 2026

Athira Pharma (NASDAQ:LONA) & Prime Medicine (NASDAQ:PRME) Financial Review - Defense World

Feb 24, 2026

Feb 23, 2026

ATHA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 23, 2026

Feb 23, 2026

BML Capital Management LLC Has $1.34 Million Stock Position in Athira Pharma, Inc. $ATHA - Defense World

Feb 23, 2026

Feb 19, 2026

LeonaBio Shares Rise After Mizuho Securities Upgrade - marketscreener.com

Feb 19, 2026

Feb 18, 2026

Mizuho upgrades LeonaBio stock rating on breast cancer drug potential By Investing.com - Investing.com Canada

Feb 18, 2026

Feb 14, 2026

Head-To-Head Contrast: Alterity Therapeutics (NASDAQ:ATHE) & Athira Pharma (NASDAQ:ATHA) - Defense World

Feb 14, 2026

Feb 14, 2026

Athira Pharma (NASDAQ:LONA) Upgraded at Wall Street Zen - Defense World

Feb 14, 2026

Feb 13, 2026

Can Athira Pharma Inc. expand into new markets2025 Price Targets & Real-Time Stock Price Movement Reports - mfd.ru

Feb 13, 2026

Feb 12, 2026

Athira Pharma (LONA) Stock Trends and Sentiment 2026 $LONA - MarketBeat

Feb 12, 2026

Feb 12, 2026

LONA News Today | Why did Athira Pharma stock drop today? - MarketBeat

Feb 12, 2026

Feb 12, 2026

Athira Pharma (LONA) Stock Price, News & Analysis $LONA - MarketBeat

Feb 12, 2026

Feb 12, 2026

Athira Pharma (LONA) Stock Chart and Price History 2026 $LONA - MarketBeat

Feb 12, 2026